(2018) Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit
trial, subjects receiving weekly doses of 30 to 60 mcg/kg (roughly 2,000 to 4,000 mcg for an 80 kg adult) showed sustained IGF-1 elevation with no serious adverse events over the study period (Teichman et al., J Clin Endocrinol Metab 2006)
it is the combination of monthly cost, medication source, oversight model, and whether your dose is anchored to your biology
Mar 2015;86(3):302-8
BPC-157 Pathways BPC-157 promotes angiogenesis via VEGF upregulation, modulates the nitric oxide system for optimal tissue perfusion, enhances expression of growth factors (FGF, EGF, TGF-), and exhibits potent anti-inflammatory activity through cytokine modulation
This texture improvement often happens before visible brightening effects, making it a great early indicator that the product is working